tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Marc Goodman, 188 are a BUY (78.01%), 47 are a HOLD (19.5%), 6 are a SELL (2.49%).
Analyst Marc Goodman, currently employed at LEERINK, carries an average stock price target met ratio of 60.61% that have a potential upside of 32.48% achieved within 253 days.
Marc Goodman’s has documented 437 price targets and ratings displayed on 42 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 11-Mar-2024.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $270 was fulfilled within 3 days with a profit of $41.55 (18.19%) receiving and performance score of 60.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$205
$39.27 (23.70%)
5 days ago
(15-Nov-2024)
2/3 (66.67%)
$39.27 (23.70%)
507
Buy
$200
$34.27 (20.68%)
$190
7 days ago
(13-Nov-2024)
12/13 (92.31%)
$28.57 (16.67%)
490
Buy
$215
$49.27 (29.73%)
$226
8 days ago
(12-Nov-2024)
8/10 (80%)
$39.86 (22.76%)
293
Buy
$224
$58.27 (35.16%)
$231
8 days ago
(12-Nov-2024)
12/15 (80%)
$48.86 (27.90%)
488
Buy
$221
$55.27 (33.35%)
$171
14 days ago
(06-Nov-2024)
22/23 (95.65%)
$18.37 (9.07%)
427
What Year was the first public recommendation made by Marc Goodman?
